Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by BayStreetWildon Oct 05, 2022 9:11pm
155 Views
Post# 35008262

RE:RE:DIMI what? What!

RE:RE:DIMI what? What!

if your glass is overflowing but if it's only half full... it looks like there's some kind of issue. Correct me if I'm wrong but shouldn't have there been a partner already announced. Hasn't this been pushed back 2 years in a row. How do you still keep up the optimism.. or do they pay you? 


mercedesman wrote:

That suggests to me that there is likely a separate deal on Dialco being discussed or in the works  


otherwise proceeds from raise would be used for both. 


Value discovery?



<< Previous
Bullboard Posts
Next >>